Ewing Sarcoma
Showing 1 - 25 of 67
Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)
Recruiting
- Ewing Sarcoma
- +2 more
- Peptide vaccine IPX
-
Frankfurt am Main, Germany
- +2 more
Oct 18, 2023
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
Chordoma, Chondrosarcoma, Ewing Sarcoma Trial in Nice (Proteus ONE one daily beam, Proteus ONE two daily beam)
Recruiting
- Chordoma
- +3 more
- Proteus ONE one daily beam
- Proteus ONE two daily beam
-
Nice, FranceCentre Antoine lacassagne
Sep 14, 2023
Ewing Sarcoma Trial in Warsaw (Naxitamab)
Not yet recruiting
- Ewing Sarcoma
-
Warsaw, Mazowian, PolandMother and Child Institute
Jul 28, 2023
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)
Not yet recruiting
- Ewing Sarcoma
- +3 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 27, 2023
Personalized Home Exercise Program in Bone Tumor Undergoing
Recruiting
- Osteosarcoma
- +3 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Mar 21, 2023
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)
Not yet recruiting
- Refractory Ewing Sarcoma
- +2 more
- (no location specified)
Feb 15, 2023
Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)
Completed
- Ependymoma
- +9 more
- Nivolumab
- NKTR-214
-
Little Rock, Arkansas
- +17 more
Dec 8, 2022
Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha
Recruiting
- Pancreatic Ductal Adenocarcinoma (PDAC)
- +6 more
-
Omaha, NebraskaUrology Cancer Center/XCancer
Nov 29, 2022
Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)
Recruiting
- Ewing Sarcoma
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 31, 2022
Breast Cancer Female, Acute Leukemia, Lymphoma Trial in Sweden (Triptorelin Embonate, Sodium Chloride solution 0.9%)
Not yet recruiting
- Breast Cancer Female
- +5 more
- Triptorelin Embonate
- Sodium Chloride solution 0.9%
-
Göteborg, Sweden
- +16 more
Oct 26, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)
Recruiting
- Ewing Sarcoma
- +5 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Ewing Sarcoma Trial in United States (drug, diagnostic test, other)
Recruiting
- Ewing Sarcoma
- Trabectedin 1 MG [Yondelis]
- +3 more
-
Los Angeles, California
- +5 more
Aug 15, 2022
Drug Sensitivity and Mutation Profiling
Recruiting
- Ewing Sarcoma
- +6 more
-
Miami, FloridaNicklaus Children's Hospital
Aug 5, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin
Completed
- Refractory or Recurrent Solid Tumors
- +3 more
- Eribulin mesilate
- Irinotecan hydrochloride
-
Marseille, Bouches-du-Rhône, France
- +38 more
Jun 20, 2022
Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,
Active, not recruiting
- Adrenal Cortex Carcinoma
- +39 more
- Cabozantinib
- +2 more
-
Birmingham, Alabama
- +142 more
May 24, 2022
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
- Cancer
- +7 more
- Blood sampling
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 17, 2022